-
NEOS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Neos Therapeutics (NEOS)
Company Profile
Quarter (USD) | Sep 20 | Jun 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 12.74 mm | 12.74 mm | 12.74 mm | 12.74 mm | 12.74 mm | 12.74 mm |
Cash burn (monthly) | (no burn) | 1.08 mm | 1.64 mm | 1.31 mm | 704.67 k | 983.58 k |
Cash used (since last report) | n/a | 57.81 mm | 87.24 mm | 69.86 mm | 37.57 mm | 52.44 mm |
Cash remaining | n/a | -45.07 mm | -74.50 mm | -57.11 mm | -24.82 mm | -39.70 mm |
Runway (months of cash) | n/a | -41.6 | -45.5 | -43.6 | -35.2 | -40.4 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 216.00 k |
Total shares | 337.26 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Goldman Sachs & Co | 337.25 k | $211.00 k |
BNP Paribas Arbitrage | 10.00 | $5.00 k |